TEOSYAL® PURESENSE DEEP LINES

Product Overview: TEOSYAL® PURESENSE DEEP LINES

TEOSYAL® PURESENSE DEEP LINES is an injectable, non-pyrogenic, transparent viscoelastic gel composed of reticulated (cross-linked) hyaluronic acid (HA) of non-animal origin, formulated with 0.3% lidocaine hydrochloride for improved patient comfort during treatment. Manufactured by Teoxane Laboratories (Geneva, Switzerland), this product is specifically developed for injection into the deep dermal layer to effectively address significant facial wrinkles and folds.

It is indicated for correcting pronounced lines, such as deep nasolabial folds and marionette lines, providing volume and support within the deep dermis.

Note: This medical device is intended for administration solely by licensed medical professionals trained and experienced in dermal filler injection techniques.

Mechanism of Action and Properties

TEOSYAL® PURESENSE DEEP LINES works by providing volume and structural support upon injection into the deep dermis. The cross-linked hyaluronic acid gel physically fills and lifts deep wrinkles and folds. Its rheological properties offer appropriate firmness and cohesivity for correcting deeper skin depressions while integrating into the tissue. The integrated 0.3% lidocaine hydrochloride provides local anesthesia, significantly reducing pain during and immediately after the procedure. The hydrophilic nature of hyaluronic acid also contributes to localized skin hydration.

The cross-linking aims to provide a durable clinical effect, typically lasting several months, though individual results and longevity depend on patient factors (age, skin type, metabolism), treatment area, injection volume, and practitioner technique.

Indications and Usage

TEOSYAL® PURESENSE DEEP LINES is indicated for the correction of deep facial wrinkles and folds, including:

• Deep nasolabial folds (smile lines)
• Pronounced marionette lines
• Other significant facial creases requiring deep dermal correction
• May potentially be used for specific contouring applications requiring deep dermal support (practitioner judgment essential)

Injection should be performed into the deep dermis by qualified practitioners using correct techniques and aseptic protocols.

Expected Outcomes

Professional application aims to deliver:

• Significant smoothing and correction of deep facial wrinkles and folds
• Restoration of volume and support within the deep dermis
• Improved facial contours in treated areas
• Enhanced patient comfort during the injection process due to lidocaine

Potential Adverse Events

Practitioners must thoroughly discuss potential side effects with patients before treatment. Possible adverse events include:

• Common Reactions (Typically Mild and Transient): Injection site reactions such as swelling, bruising, erythema (redness), pain, tenderness, itching, or palpable firmness/lumps. These generally resolve within several days to a week.
• Less Common/Rare but Serious Reactions: Prolonged swelling or induration; significant hematoma; infection; inflammatory reactions (sometimes delayed); hypersensitivity/allergic reactions (to HA or lidocaine); formation of persistent nodules or granulomas; skin discoloration; abscess formation; contour irregularities; vascular complications (rare but serious, including potential necrosis or embolism if accidentally injected into a blood vessel); temporary nerve effects.

Comprehensive knowledge of facial anatomy, safe injection techniques, and management of potential complications is crucial. Patients should report any severe, persistent, or concerning reactions immediately.

Storage Conditions

Store between 2°C and 25°C. Protect from freezing temperatures and direct sunlight. Verify package integrity before use.

Disclaimer: This information serves as a general guide. Healthcare professionals must consult the full instructions provided with TEOSYAL® PURESENSE DEEP LINES before administration for complete details on product characteristics, indications, contraindications, warnings, precautions, injection procedures, and potential adverse events.